Mitsubishi Tanabe's sales static, but recall impact to be limited
This article was originally published in Scrip
Executive Summary
Amid a swirl of controversy over a major recall of products in its home market, Japan's Mitsubishi Tanabe Pharma (MTP) has reported static sales in the nine months to 31 December.